Technology
Intero Biosystems offers lab-grown mini intestines to replace animal tests
Intero Biosystems is addressing the high failure rate of pharmaceutical drugs by providing laboratory-grown human intestinal organoids. These tiny tissues allow researchers to evaluate safety and efficacy more accurately than traditional animal models, as they better reflect human biology. Regulatory shifts, including updated U.S. Food and Drug Administration guidelines, are encouraging developers to adopt alternative testing methodologies. The startup currently supplies thousands of these living models to industry clients while working toward mass production, custom testing services, and future personalized medicine applications.